Bailard Inc. Purchases 5,494 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Bailard Inc. grew its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV) by 35.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 21,194 shares of the company’s stock after buying an additional 5,494 shares during the period. Bailard Inc.’s holdings in ZimVie were worth $296,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently modified their holdings of ZIMV. SG Americas Securities LLC boosted its holdings in ZimVie by 15.7% in the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock worth $155,000 after buying an additional 1,508 shares during the period. EMC Capital Management lifted its position in shares of ZimVie by 47.0% during the fourth quarter. EMC Capital Management now owns 13,802 shares of the company’s stock worth $193,000 after acquiring an additional 4,414 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in shares of ZimVie by 9.8% in the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company’s stock worth $266,000 after acquiring an additional 1,702 shares during the period. Dynamic Technology Lab Private Ltd purchased a new position in shares of ZimVie in the third quarter valued at $470,000. Finally, Y Intercept Hong Kong Ltd purchased a new position in shares of ZimVie in the third quarter valued at $528,000. Hedge funds and other institutional investors own 95.63% of the company’s stock.

Analysts Set New Price Targets

Separately, Needham & Company LLC reiterated a “buy” rating and set a $23.00 price target on shares of ZimVie in a research report on Thursday, February 27th.

ZimVie Trading Down 0.7 %

Shares of ZIMV stock opened at $13.35 on Thursday. The company has a market capitalization of $369.49 million, a PE ratio of -1.02 and a beta of 2.10. ZimVie Inc. has a 52-week low of $12.25 and a 52-week high of $22.40. The business’s fifty day moving average is $13.73 and its 200 day moving average is $14.66. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94.

ZimVie (NASDAQ:ZIMV) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.25 by $0.02. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The company had revenue of $111.52 million during the quarter, compared to analyst estimates of $113.67 million. On average, equities research analysts anticipate that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.